15% of the couples are globally affected by infertility, with male-factor accounting for 50% of the global infertility.
DECREASE IN SPERM COUNT SINCE 1970S
UNEXPLAINED MALE INFERTILITY
IVF CYCLES PERFORMED ANNUALLY
Spermosens’ patent-pending technology is based on the 2014 discovery of the JUNO protein, and has emanated in a user friendly and small footprint diagnostic system which in 30 minutes predicts the fusion capacity of the sperms.
Breakthrough Platform technology
This will lead to an immediate decision if the sperm sample is suitable for standard-IVF or ICSI, thus drastically limiting the number of cycles required for fertilisation and reducing the burden of infertility on the female partner.
Millions of couples waiting in queue for 1-3 years for IVF can now be helped quicker and more economically.